Cingulate Inc.
做多
已更新

$CING - Low Float - Positive Top Line Results - ADHD 1 PILL

49
We are traveling the bottom of the channel. I think it starts to move up shortly. Adolescent and Pediatric fixed dose phase 3 trials start this month and next month. FDA approval submission early/mid next year. Billion-dollar drug if it can get some funding? This is my own opinion, and you should not take any of this as financial advice.
注释
Curious what this would mean for the current producers of such meds like JNJ, PFE, NVS? I'm assuming they would buy out Cingulate quickly before something like that dented their sales.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。